GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

Symbol: INMB on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$689,170	441,650	-27,790	-5.9%	$1.56	Q4 2025
30 Sep 2025	0%	+0%	$972,014	469,440	+79,509	+20%	$2.07	Q3 2025
30 Jun 2025	0%	+0%	$901,023	389,931	+25,069	+6.9%	$2.31	Q2 2025
31 Mar 2025	0%	+0%	$2,849,867	364,862	+1,260		$7.81	Q1 2025
31 Dec 2024	0%	+0%	$1,698,197	363,602	+19,136	+5.6%	$4.67	Q4 2024
30 Sep 2024	0%	+0%	$1,856,834	344,466	+21,262	+6.6%	$5.39	Q3 2024
30 Jun 2024	0%	+0%	$2,850,938	323,204	+152,402	+89%	$8.82	Q2 2024
31 Mar 2024	0%	+0%	$2,007,281	170,802	+762	+0.45%	$11.75	Q1 2024
31 Dec 2023	0%	+0%	$1,914,965	170,040	+2,937	+1.8%	$11.26	Q4 2023
30 Sep 2023	0%	+0%	$1,143,195	167,103	+12,423	+8%	$6.84	Q3 2023
30 Jun 2023	0%	+0%	$1,404,494	154,680	+11,023	+7.7%	$9.08	Q2 2023
31 Mar 2023	0%	+0%	$928,024	143,657	+660	+0.46%	$6.46	Q1 2023
31 Dec 2022	0%	+0%	$906,000	142,997	+3,391	+2.4%	$6.34	Q4 2022
30 Sep 2022	0%	+0%	$865,000	139,606	+1,382	+1%	$6.20	Q3 2022
30 Jun 2022	0%	+0%	$1,221,000	138,224	+10,695	+8.4%	$8.83	Q2 2022
31 Mar 2022	0%	+0%	$1,073,000	127,529	+9,259	+7.8%	$8.41	Q1 2022
31 Dec 2021	0%	+0%	$1,206,000	118,270	+28,663	+32%	$10.20	Q4 2021
30 Sep 2021	0%	+0%	$1,740,000	89,607	+15,813	+21%	$19.42	Q3 2021
30 Jun 2021	0%	+0%	$1,296,000	73,794	+12,957	+21%	$17.56	Q2 2021
31 Mar 2021	0%	+0%	$722,000	60,837	+27,182	+81%	$11.87	Q1 2021
31 Dec 2020	0%	+0%	$579,000	33,655	+3,632	+12%	$17.20	Q4 2020
30 Sep 2020	0%	+0%	$309,000	30,023	+30,023	NEW	$10.29	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.